Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Cepheid’s molecular test determines ER/PR/HER2/Ki-67 with less variable results compared to IHC/FISH

Please log in for more information

 

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Company Information

Visit www.cepheid.com/en to view our entire portfolio of molecular diagnostic tests and systems.

1. CE-IVD. In Vitro Medical Device. Not available in all countries. Not available in the United States. 
2. Xpert® Breast Cancer STRAT4 Package Insert. Sunnyvale. USA. 2017

Contact Information:

Cepheid | Vira Solelh | 81470 Maurens-Scopont, France
PHONE +33.563.82.53.00
FAX +33.563.82.53.01

Company website

About Cepheid's Oncology Tests

Cepheid’s innovative oncology program offers a growing menu of molecular diagnostic tests that currently focuses on cancers of the breast, bladder, and blood. Leveraging Cepheid’s proven molecular diagnostics platform, our oncology products deliver on-site, on-demand, accurate, and reliable results. The pioneering mindset of our team is bolstered by Cepheid’s strong molecular biology capabilities, extensive global infrastructure, and an unwavering commitment to scientific rigor. Our vision is to deliver life-changing technology to physicians and their cancer patients globally.

Related Application Notes

Alissa Clinical Informatics Platform Compendium 2nd Edition

| Contributed by Agilent

Delivering precision health: the role of molecular diagnostics

| Contributed by GE

NGS technology: Trends and clinical applications

| Contributed by GE

Newsletter

Send me the latest from The Pathologist.

Sign up now

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register